+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medpace Holdings Inc (MEDP) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 40 Pages
  • May 2023
  • GlobalData
  • ID: 4395076
Medpace Holdings Inc (MEDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medpace Holdings Inc (Medpace) is a clinical research organization that provides outsourced clinical development services. It provides full-service Phase I to Phase IV clinical trial services, project management, regulatory affairs, data management, clinical monitoring, and post-market clinical support. The company also provides clinical human pharmacology, bio-analytical laboratory services, electrocardiography reading support, and various imaging services. Medpace carries out clinical trials of products for various conditions in cardiology, metabolic disease, endocrinology, central nervous system (CNS), oncology, and antiviral and anti-infective (AVAI). It serves biopharmaceutical, pharmaceutical, biotechnology and medical device companies in North America, Europe, Africa, Middle East, Asia Pacific, and Latin America. Medpace is headquartered in Cincinnati, Ohio, the US.

Medpace Holdings Inc Key Recent Developments

  • Jul 25, 2022: Medpace Holdings, Inc. Reports Second Quarter 2022 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Medpace Holdings Inc - Key Facts
  • Medpace Holdings Inc - Key Employees
  • Medpace Holdings Inc - Key Employee Biographies
  • Medpace Holdings Inc - Major Products and Services
  • Medpace Holdings Inc - History
  • Medpace Holdings Inc - Company Statement
  • Medpace Holdings Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Medpace Holdings Inc - Business Description
  • Product Category: AVAI
  • Performance
  • Product Category: Cardiology
  • Performance
  • Product Category: Central Nervous System
  • Performance
  • Product Category: Metabolic
  • Performance
  • Product Category: Oncology
  • Performance
  • Product Category: Other
  • Performance
  • Medpace Holdings Inc - Corporate Strategy
  • Medpace Holdings Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Medpace Holdings Inc - Strengths
  • Medpace Holdings Inc - Weaknesses
  • Medpace Holdings Inc - Opportunities
  • Medpace Holdings Inc - Threats
  • Medpace Holdings Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Medpace Holdings Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 25, 2022: Medpace Holdings, Inc. Reports Second Quarter 2022 Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Medpace Holdings Inc, Key Facts
  • Medpace Holdings Inc, Key Employees
  • Medpace Holdings Inc, Key Employee Biographies
  • Medpace Holdings Inc, Major Products and Services
  • Medpace Holdings Inc, History
  • Medpace Holdings Inc, Other Locations
  • Medpace Holdings Inc, Subsidiaries
  • Medpace Holdings Inc, Key Competitors
  • Medpace Holdings Inc, Ratios based on current share price
  • Medpace Holdings Inc, Annual Ratios
  • Medpace Holdings Inc, Interim Ratios
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Medpace Holdings Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Medpace Holdings Inc, Performance Chart (2018 - 2022)
  • Medpace Holdings Inc, Ratio Charts
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • IQVIA Holdings Inc
  • Parexel International Corp
  • ICON Plc
  • Syneos Health Inc
  • PRA Health Sciences Inc
  • Laboratory Corporation of America Holdings - Clinical Trials Testing Division
  • PPD Inc